NIFTAS

1.Product Overview
Brand Name: Niftas
Generic Name: Nitrofurantoin Sustained Release Tablets
Product Type: Prescription Medicine (Schedule H Drug)
Form: Film-coated sustained-release tablet
Specifications & Ingredients
Active Ingredient: Each film-coated sustained-release tablet contains Nitrofurantoin IP (100 mg).
Other Ingredients: Titanium Dioxide IP (color) and Excipients (Q.S. – Quantum Satis/as much as is sufficient).
2.General Information
Drug Classification: This is a Schedule H prescription drug. The label explicitly states: “Not to be sold by retail without the prescription of a Registered Medical Practitioner.”
Storage Conditions: Store in a cool & dry place, protected from light. Keep all medicines out of reach of children.
Food Preference/FSSAI: Not applicable (this is a pharmaceutical product, not a food or dietary supplement).
Note: The packaging includes a QR code for identification/tracking.
3.Directions for Use
How to take: The tablet must be swallowed as a whole.
Precautions: Do not chew or crush the tablet.
Dosage: As directed by the physician.
Manufacturer Information
4.Manufactured by: Intas Pharmaceuticals Ltd.
Manufacturing Facility Location: Bagheykhola, Majhitar, Sikkim-737 136, INDIA.
Manufacturing License No.: M/517/09                                                                                                                5.Marketed by : Intas Pharmaceuticals Ltd.
6.Description : Product Purpose: Niftas (Nitrofurantoin) is an antibiotic used to treat bacterial urinary tract infections (UTIs). The “Sustained Release” (SR) formulation is designed to release the medication slowly into the body over time, which helps maintain stable drug levels and may improve tolerance.